Cargando…
Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734506/ https://www.ncbi.nlm.nih.gov/pubmed/36473998 http://dx.doi.org/10.1038/s41380-022-01839-6 |
| _version_ | 1784846595882221568 |
|---|---|
| author | de Paula, Jonas J. Duran, Fabio L. S. Busatto, Geraldo Miranda, Debora M. Romano-Silva, Marco A. |
| author_facet | de Paula, Jonas J. Duran, Fabio L. S. Busatto, Geraldo Miranda, Debora M. Romano-Silva, Marco A. |
| author_sort | de Paula, Jonas J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9734506 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97345062022-12-12 Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 de Paula, Jonas J. Duran, Fabio L. S. Busatto, Geraldo Miranda, Debora M. Romano-Silva, Marco A. Mol Psychiatry Correspondence Nature Publishing Group UK 2022-12-06 2023 /pmc/articles/PMC9734506/ /pubmed/36473998 http://dx.doi.org/10.1038/s41380-022-01839-6 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence de Paula, Jonas J. Duran, Fabio L. S. Busatto, Geraldo Miranda, Debora M. Romano-Silva, Marco A. Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 |
| title | Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 |
| title_full | Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 |
| title_fullStr | Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 |
| title_full_unstemmed | Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 |
| title_short | Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022 |
| title_sort | reply to “predominance of visuoconstructive impairment after mild covid-19?” by díez-cirarda et al. 2022 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734506/ https://www.ncbi.nlm.nih.gov/pubmed/36473998 http://dx.doi.org/10.1038/s41380-022-01839-6 |
| work_keys_str_mv | AT depaulajonasj replytopredominanceofvisuoconstructiveimpairmentaftermildcovid19bydiezcirardaetal2022 AT duranfabiols replytopredominanceofvisuoconstructiveimpairmentaftermildcovid19bydiezcirardaetal2022 AT busattogeraldo replytopredominanceofvisuoconstructiveimpairmentaftermildcovid19bydiezcirardaetal2022 AT mirandadeboram replytopredominanceofvisuoconstructiveimpairmentaftermildcovid19bydiezcirardaetal2022 AT romanosilvamarcoa replytopredominanceofvisuoconstructiveimpairmentaftermildcovid19bydiezcirardaetal2022 |